Core Viewpoint - Yantai Jiumu Chemical Co., Ltd. (hereinafter referred to as Jiumu Chemical), backed by Wanrun Co., Ltd., is preparing for an IPO on the Beijing Stock Exchange, but faces concerns regarding its financial performance and inventory levels [1][3]. Company Overview - Jiumu Chemical specializes in the research, production, and sales of OLED (Organic Light Emitting Diode) front-end materials, including OLED sublimation precursor materials and intermediates [4]. - The company was established in 2005 and became a subsidiary of Wanrun Co., Ltd. after its acquisition in 2010, with Wanrun currently holding 45.33% of Jiumu Chemical's shares [4][5]. Financial Performance - Jiumu Chemical's revenue increased from 706 million yuan in 2022 to 962 million yuan in 2024, while net profit rose from 204 million yuan to 254 million yuan during the same period [8]. - However, in the first three quarters of the current year, the company reported a revenue decline of 17.36% year-on-year, totaling 611 million yuan, and a net profit drop of 23.47%, amounting to 154 million yuan [8][9]. Inventory Concerns - The company's inventory has surged to 523 million yuan, a year-on-year increase of approximately 25.12%, raising questions about potential unsold stock [9]. - Inventory accounted for 66.78% of current assets as of the third quarter, up from 58.58% in 2022 [9]. Expansion Plans - Despite the underutilization of production capacity (below 80%), Jiumu Chemical plans to raise 1 billion yuan for expansion, aiming to add 280 tons of OLED front-end materials capacity [3][9]. - The company's production capacity utilization rate has significantly decreased from 108.54% in 2022 to 68.08% in 2023 [9]. Shareholder Activity - Notable shareholders include individuals who have realized substantial profits from their investments, with one individual reportedly cashing out over 300 million yuan [5][6]. - The shareholder structure includes institutional investors, with some having exited their positions shortly after investing [6][8].

背靠万润股份的OLED材料商烟台九目化学股份有限公司（以下简称"九目化学"）正冲刺北交所上市。 "露笑系"家族入股 与自然人套现离场 九目化学主要从事OLED前端材料的研发、生产和销售，主要产品包括OLED升华前材料、OLED中间体等功能性材料。 其股东名单堪称"藏龙卧虎"，既有"露笑系"儿媳隐身其后，更有两名神秘自然人3年时间套现近5亿元，其中获利超过3亿元。 公司成立于2005年，最初由部分万润股份职工等共同出资设立。2010年，万润股份完成对九目化学的收购，使其成为控股子公司。 万润股份早在2011年于深交所上市，实际控制人为中国节能，后者的出资人为国务院国有资产监督管理委员会。至今，万润股份仍然持有九目化学 45.33%的股份，为公司控股股东。 | | | | | | 普通股前十名股东情况 | | | | 年11: 成 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 序 목 | 股东名 称 | 期初持 股数 | 持股变 动 | 期末持 股数 | 期末持 股比 例% | 期末持 有限管 股份数 | 期末持 有灵 售股份 ...

Core Viewpoint - Yantai Jiumu Chemical Co., Ltd., backed by Wanrun Co., is pushing for an IPO on the Beijing Stock Exchange, despite facing declining profits and rising inventory levels [1][2]. Company Overview - Jiumu Chemical specializes in the research, production, and sales of OLED front-end materials, including sublimation materials and intermediates [3]. - The company was established in 2005 and became a subsidiary of Wanrun Co. after its acquisition in 2010. Wanrun Co. holds a 45.33% stake in Jiumu Chemical [4]. Shareholder Dynamics - The shareholder list includes notable figures, such as the daughter-in-law of the Lu Xiao Jun family, and two mysterious individuals who cashed out nearly 500 million yuan over three years, with profits exceeding 300 million yuan [2][6]. - Significant changes in shareholding occurred shortly after capital increases, with major investors realizing substantial profits from their investments [6][7]. Financial Performance - In the first three quarters of this year, Jiumu Chemical reported a revenue of 611 million yuan, a year-on-year decline of 17.36%, and a net profit of 154 million yuan, down 23.47% [10]. - The company's inventory has surged to 523 million yuan, raising concerns about potential unsold stock [10][11]. Market Conditions - The OLED industry is experiencing an oversupply, impacting the pricing of Jiumu Chemical's core products. The average price of OLED sublimation materials fell by approximately 15.7% from the previous year [10]. - Despite the declining demand and profitability, the company plans to raise 1 billion yuan for expansion, aiming to add 280 tons of production capacity for OLED materials [11]. Production Capacity and Utilization - Following the launch of its first-phase project, the company's production capacity utilization dropped significantly from 108.54% in 2022 to 68.08% in 2023, with a further decline to 74.24% in early 2025 [11].

Core Viewpoint - Yantai Jiumu Chemical Co., Ltd. (hereinafter referred to as "Jiumu Chemical"), backed by Wanrun Co., Ltd., is racing towards its listing on the Beijing Stock Exchange, but faces challenges with declining profits and rising inventory levels amid plans for significant capacity expansion [1][2]. Shareholder Structure - Jiumu Chemical's shareholder list includes notable figures, such as the daughter-in-law of the "Luxiao system" and two mysterious individuals who cashed out nearly 500 million yuan in three years, with profits exceeding 300 million yuan [2][3]. - Wanrun Co., Ltd. holds a 45.33% stake in Jiumu Chemical, making it the controlling shareholder [3]. Financial Performance - In the first three quarters of this year, Jiumu Chemical's net profit declined by over 20%, while inventory surged to 523 million yuan [2][9]. - Revenue fell by 17.36% year-on-year to 611 million yuan, with a net profit of 154 million yuan, down 23.47% [9]. - The average selling price of Jiumu Chemical's core product, OLED sublimation front materials, decreased by approximately 15.7% from the previous year [9]. Capacity Expansion Plans - Despite a production capacity utilization rate of less than 80%, Jiumu Chemical plans to raise 1 billion yuan for significant capacity expansion, aiming to add 280 tons of OLED front-end materials and other functional materials [10]. - The company has faced scrutiny from the exchange regarding the necessity and rationality of this expansion given the current underutilization of existing capacity [10]. Dividend History - Prior to the planned fundraising for expansion, Jiumu Chemical distributed substantial cash dividends totaling over 200 million yuan from March 2022 to May 2025 [10].

Core Viewpoint - Yantai Jiumu Chemical Co., Ltd. (hereinafter referred to as "Jiumu Chemical"), backed by Wanrun Co., Ltd., is racing towards its listing on the Beijing Stock Exchange, but its fundamentals show signs of concern as net profit has dropped over 20% in the first three quarters of this year, while inventory has surged to 523 million yuan [1][4]. Group 1: Company Background - Jiumu Chemical specializes in the research, production, and sales of OLED front-end materials, including OLED sublimation materials and intermediates [2]. - Established in 2005, Jiumu Chemical became a subsidiary of Wanrun Co., Ltd. after its acquisition in 2010, with Wanrun holding 45.33% of Jiumu's shares [2]. Group 2: Shareholder Dynamics - The shareholder list of Jiumu Chemical includes institutional and individual investors, with significant transactions involving natural persons who have cashed out nearly 500 million yuan over three years, yielding profits exceeding 300 million yuan [1][3]. - Notably, the "Luxiao Group" and other institutions entered the shareholder structure in 2018, with initial investments at 1.81 yuan per registered capital [2]. Group 3: Financial Performance - Jiumu Chemical's revenue grew from 706 million yuan in 2022 to 962 million yuan in 2024, but the net profit has seen a decline, with a 17.36% drop in revenue to 611 million yuan and a 23.47% decrease in net profit to 154 million yuan in the first three quarters of this year [4][5]. - The average selling price of Jiumu's core product, OLED sublimation materials, has decreased by approximately 15.7% from 5,265.85 million yuan per ton in 2024 to 4,439.75 million yuan per ton in the first quarter of this year [5]. Group 4: Inventory and Expansion Plans - Jiumu Chemical's inventory has increased significantly, reaching 523 million yuan by the end of the third quarter, a rise of about 25.12% compared to the previous year [5][6]. - Despite the low capacity utilization rate of below 80%, the company plans to raise 1 billion yuan for expansion, aiming to add 280 tons of OLED front-end materials capacity [6]. Group 5: Market Context - The OLED industry is currently facing an oversupply situation, which has affected demand and pricing for Jiumu Chemical's products [4][5].

Core Viewpoint - The company is facing a significant test of confidence and efficiency as it plans to issue 766 million yuan in convertible bonds to invest in cutting-edge perovskite material production and R&D projects, despite strong performance in revenue and net profit for the first three quarters of 2025 [1][3]. Financing Plan - The fundraising plan aims to raise no more than 766 million yuan, primarily allocated to four areas: construction of production workshops in the "Pucheng Light Optoelectronics New Materials Production R&D Base," smart upgrade of production workshops, establishment of a perovskite material R&D and device verification platform, and supplementing working capital [3]. Previous Fund Utilization - As of September 30, 2025, the company had utilized 603 million yuan of the previous fundraising net amount of 805 million yuan, leaving approximately 231 million yuan (25.11%) unspent. The remaining funds will continue to support the "OLED terminal material R&D and industrialization project," which has faced two delays [5]. Project Delays - The "OLED terminal material R&D and industrialization project" has been postponed twice, with the completion date now extended to August 2026. The company cites economic conditions, industry competition, and market demand changes as reasons for the delays, emphasizing a cautious approach to project implementation and funding allocation [5]. Shareholder Actions - Major shareholders, including Junlian Chengye and Junlian Huicheng, have been reducing their holdings since the expiration of the lock-up period, with a total reduction of 1.73% from April 2023 to October 2024. By June 2025, their combined shareholding had decreased to 3.9% [7][8]. Board Restructuring - The company has significantly reduced its board size from 11 to 7 members, with several directors resigning, including those recommended by the major shareholders. This restructuring reflects changes in the company's governance and shareholder influence [7][8]. Financial Performance - For the first three quarters of 2025, the company reported a revenue of 423 million yuan, an increase of 18.77% year-on-year, and a net profit of 180 million yuan, representing a substantial growth of 38.62% [8]. Strategic Challenges - The company faces the challenge of balancing project management and funding efficiency amid ongoing shareholder changes and governance restructuring, which will be crucial for its future development [1][8].

Core Viewpoint - Aolide (688378.SH) announced the withdrawal of its application for a simplified procedure to issue shares to specific targets and plans to resubmit the application after adjusting its financing plan based on regulatory considerations and business development [1]. Financing Plan - The company initially planned to raise a total of up to 269.86 million yuan (approximately 26.99 million) through the issuance of shares, with a maximum of 300 million yuan and not exceeding 20% of the net assets at the end of the last fiscal year [1]. - The net proceeds from the fundraising were intended for the OLED display core material PSPI production base project and to supplement working capital [1]. - The proposed issue price was set at 17.20 yuan per share [1]. Shareholders and Ownership - The issuance was targeted at several investors, including individuals and fund management companies, all subscribing in cash at the same price [2]. - The major shareholders, Xuan Jingquan and Xuan Lingyi, control 33.39% of the company's shares, significantly influencing management decisions [4][5]. - The company has undergone share transfers, with a recent transfer involving 6,244,447 shares at a price of 21.00 yuan per share, totaling approximately 131 million yuan [4]. Financial Performance - In 2024, Aolide reported revenues of 533 million yuan, a 3% increase year-on-year, but net profit attributable to shareholders decreased by 26.04% to approximately 90.43 million yuan [11]. - For the first three quarters of 2025, the company experienced a 16.12% decline in revenue, totaling 389 million yuan, and a significant 69.03% drop in net profit to approximately 31.36 million yuan [12].

Core Viewpoint - The report from CITIC Construction Investment suggests focusing on sectors that are expected to benefit from the "anti-involution" trend, as the chemical industry faces a slowdown in capital expenditure and an approaching cyclical turning point [1] Group 1: Beneficial Sectors - Recommended sectors include pesticides, urea, soda ash, filament, organic silicon, and spandex, which are likely to benefit from the "anti-involution" trend [1] - In the context of a declining interest rate cycle, China's counter-cyclical policies are expected to boost domestic demand, making sectors like polyurethane, coal chemical, petroleum chemical, and fluorochemical attractive [1] Group 2: New Material Development - The development of new productive forces, self-control, and industrial upgrading are emphasized as key strategies in the context of major power competition, with new materials being a primary development direction for China's chemical industry [1] - Focus areas include semiconductor materials, OLED materials, COC materials, and other high value-added products [1] Group 3: High Shareholder Returns - High-quality companies with substantial shareholder returns are expected to continue their revaluation journey, particularly state-owned enterprises in the oil and gas petrochemical sector, coal chemical, compound fertilizer, phosphorus chemical, and leading companies in the MSG/feed amino acid industry [1]

Core Viewpoint - The report from CITIC Construction Investment suggests focusing on specific sectors within the chemical industry that are expected to benefit from the "anti-involution" trend and the upcoming economic cycle shift, while also highlighting the importance of new material development in the context of national competition [1] Group 1: Investment Recommendations - Attention is recommended for sectors such as pesticides, urea, soda ash, long fibers, organic silicon, and spandex, which are likely to benefit from the "anti-involution" trend [1] - In the context of a declining interest rate cycle, sectors like polyurethane, coal chemical, petroleum chemical, and fluorochemical are suggested for investment as they may help stimulate domestic demand [1] Group 2: Development Focus - The report emphasizes the development of new productive forces, self-sufficiency, and industrial upgrades as key strategies in the context of major power competition, with new materials being a primary focus for the Chinese chemical industry [1] - Specific attention is drawn to the continuous development of semiconductor materials, OLED materials, COC materials, and other high value-added products [1] Group 3: Quality Enterprises - High shareholder returns from quality enterprises are expected to continue their revaluation journey, with a focus on leading state-owned enterprises in oil and gas, coal chemical, compound fertilizer, phosphorus chemical, and amino acid industries for feed and flavoring [1]

Core Viewpoint - Universal Display Corporation (UDC) reported a decline in revenue and profit for Q3 2025 compared to the same period last year, primarily due to customer shipment schedule adjustments and one-time accounting changes, but overall operations remain robust [1][5]. Financial Performance Summary - UDC's total revenue for Q3 2025 was $139.613 million (approximately ¥1.005 billion), a decrease of about 14% from $161.627 million in Q3 2024 [2][5]. - Material sales revenue was $82.634 million, nearly flat compared to $83.428 million in the previous year [4][5]. - Royalty and license fees dropped to $53.317 million from $74.590 million, largely due to changes in customer structure and a one-time adjustment of approximately $9.5 million [4][5]. - Gross margin for material sales was 60%, consistent with the previous year, while overall gross margin was 75%, slightly down from 78% year-on-year [4][5]. Year-to-Date Performance - For the first three quarters of 2025, UDC's cumulative revenue reached $477.684 million (approximately ¥3.44 billion), a slight decline from $485.391 million in the same period of 2024 [6][7]. - Material sales for the nine months totaled $257.439 million, down from $272.154 million, while royalty and license fees were $202.553 million, slightly up from $202.409 million [6][7]. - The net profit for the first three quarters was $175.7 million, with diluted earnings per share at $3.68, remaining stable compared to the previous year [7]. Future Outlook - UDC anticipates total revenue for 2025 to be at the lower end of its previous guidance, around $650 million, reflecting changes in customer purchasing patterns and market demand fluctuations [8]. - The company remains optimistic about future growth prospects, driven by the promotion of next-generation efficient OLED materials and the expansion of new application markets [8]. - UDC announced the acquisition of over 300 OLED-related patent assets from Merck Group to strengthen its technological leadership in high-efficiency OLED devices [8].